Compound 1332
Identifiers
- Canonical SMILES:
CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(CCc2cnc3ccccc3c2)[C@@H](CC(C)C)C1=O
- IUPAC name:
(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(2-quinolin-3-ylethyl)-1,4-diazepan-1-yl]-3-naphthalen-2-ylpropanamide
- InChi:
InChI=1S/C34H38N4O3/c1-23(2)18-31-34(41)38(30(33(40)35-3)21-24-12-13-26-8-4-5-9-27(26)19-24)17-15-32(39)37(31)16-14-25-20-28-10-6-7-11-29(28)36-22-25/h4-13,19-20,22-23,30-31H,14-18,21H2,1-3H3,(H,35,40)/t30-,31-/m0/s1
- InChiKey:
PIDWOXMITGALID-CONSDPRKSA-N
External links
![]() 12109929 |
![]() CHEMBL440377 |
![]() 23245214 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.05 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 550.29 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 4.58 | |||
TPSA | 82.61 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8254 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.7857 | Gramicidin D | DB00027 | |
0.7716 | LTX-315 | DB12748 | |
0.7609 | Anamorelin | DB06645 | |
0.7574 | Murepavadin | DB14777 | |
0.7299 | BQ-123 | DB12054 | |
0.7231 | Macimorelin | DB13074 | |
0.7174 | Somatoprim | DB12777 | |
0.7101 | Omiganan | DB06610 | |
0.7000 | Abarelix | DB00106 | |
0.6985 | Ilomastat | DB02255 | |
0.6808 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
0.6761 | N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE | DB08489 | |
0.6731 | Tifuvirtide | DB05413 | |
0.6731 | Barusiban | DB12292 |